Advanced Endo 1 Flashcards
Congenital hypothyroidism?
CF: normal at birth, age<1month (jaundice, poor feeding, hypothermia), age 1-4months ( FTT, constipation)
Dx: newborn screening, inc. TSH & dec T4
Congenital hypothyroidism?
Mxn: confirm TSH/T4, start levothyroxine immediately, order usg thyroid, refer to endocrinologist
Prognosis: excellent e rxn, at risk for permanent neurological defects wout rxn
Primary hyperparathyroidism?
Etiology: parathyroid adenoma/hyperplasia/carcinoma, inc risk in MEN 1 & 2A
CF: asymptomatic( most common), mild/nonspeciific symptoms( fatigue, constipation), abdominal pain, bone pain, renal stones, neuropsychiatric symptoms
Primary hyperparathyroidism?
Dx findings: hypercalcemia, elevated or inappropriately normal PTH, elevated 24 hr urinary ca excretion
Indications for parathyroidectomy?
Age <50, symptomatic hypercalcemia, complications; osteoporosis (T score <-2.5, fragility fracture), nephrolothiasis/ calcinosis, CKD (GFR <60mL/min), elevated risk of complications; ca >_ 1 mg/dl above normal, urinary ca excretion > 400mg/day
Familial hypercalciuric hypercalcemia?
Positive family history
Urinary ca excretion < 200mg/day
Primary hypothyroidism: ?
A/w pernicious anemia( autoimmune)
Pernicious: due to intrinsic factor deficiency due autoimmune destruction of parietal cells
CF: involvement of post & lateral column; ataxia/ loss of proprioception/ vibration, peripheral neuropathy, weakness, spasticity
Symptoms more prominent in lower than upper extremities
Treating e vit b12; what to notice?
Vit b12 treatment in moderate- sever megaloblastic anemia may lead to severe/life threatening hypokalemia due to uptake of K by newly formed RBCs
Serum K monitored during first 48 hrs and replacement done depending on measured levels.
Some transfuse PRBCs in severe megaloblastic anemia before vit b12 supplementation to prevent hypokalemia
Effects of combined estrogen/progesterone menopausal hormone therapy?
Beneficial: menopausal symptoms( hot flashes/vaginal atrophy), bone mass/fractures, colon ca, type 2 DM, all cause mortality( age<60)
Detrimental: VTE, breast ca, CHD(age>60), stroke, gall bladder disease
Neutral: cognition/dementia, endometrial ca( inc e unopposed estrogen), ovarian ca, all cause mortality age> 60)
Osteoporosis & osteopenia?
Normal: Tscore -1 or greater
Low bone mass(osteopenia): Tscore -1 to -2.5
Osteoporosis: Tscore -2.5 or less or history of fragility fracture
Screening for osteoporosis?
Women age>_ 65 or postmenopausal women <65 e additional risk factors for osteoporosis; low body weight, current smoking, FHO hip fracture, use of glucocorticoids
Postmenopausal counselled on preventive measures such as weight bearing exercises, intake of calcium & vitamin D
Osteoporosis: bisphosphonates indications?
Low bone mass e h/o fragility fracture
Bone density criteria for osteoporosis( Tscore <-2.5 on DXA)
Osteopenia (Tscore betn -1 & -2.5) e 10 yr probability for major osteoporotic fracture >_ 20% or hip fracture >_ 3% based on FRAX risk calculator
Pubertal gynecomastia?
Etiology: imbalance betn estrogen & androgens during mid puberty(tanner stage 3-4)
CF: small(<4cm), firm, unilateral or bilateral subareolar mass/ no pathologic features( nipple discharge, axillary lympadenopathy, systemic illness)
Mxn: reassurance & observation, resolves ein 1 yr
Pseudogynecomastia?
Deposition of fat in overweight or obese boys
Difference betn pseudo & physiologic gynecomastia: no palpable mass in pseudo gynecomastia
Metformin side effects?
GI upset( nauseas, abdominal pain, diarrhea), dec intestinal vit b12 absorption & lactic acidosis( rare but fatal); lactic acidosis incidence higher in abnormal renal function(cr>1.5 mg/dl in men, >1.4mg/dl in women or cr clearance <60mL/min) or hepatic dysfunction Other CIs for metformin: alcohol abuse, sepsis, CHF
Metformin & cardiac catheterization ?
Metformin when given e large dose iodine contrast( cardiac catheterization) inc risk of lactic acidosis so metformin is stopped on day of IV iodine contrast exposure and restart atleast 48 hrs after procedure
Impaired fasting blood glucose?
Range betn: 100-126 mg/dl, above 126mg/dl is diabetes
People e impaired blood glucose levels has inc risk of coronary artery disease and progression to overt diabetes
Choice of rxn in graves hyperthyroidism?
- Antithyroid drugs: mild hyperthyroidism, older age e limited life expectancy, preparation for RAIU or surgery, pregnant ( PTU in 1st trimester)
- RAIU: moderate to severe hyperthyroidism e or eout mild opthalmopathy, pt preference in mild hyperthyroidism
- Thyroidectomy: very large goiter, suspected thyroid cancer, coexisting primary hyperparathyroidism, pg pts who cannot tolerate thionamides, severe opthalmopathy, retrosternal goitre e obstructive symptoms
# should be started e beta blockers & antithyroid to achieve euthyroid state
Choice of rxn in graves hyperthyroidism?
Antithyoid drugs: methazole preferred due to risk of hepatotoxicity e propylthiouracil
RAI: contraindicated in pregnant and lactation
Evaluation of antithyroid drug efficacy?
Lab evaluation done 4-6 wks later after starting antithyroid drugs and then every 2-3 months.
TSH may remain suppressed for many months after initiation of therapy & does not accurately reflect thyroid function status. So total T3 & free T4 should be used to assess efficacy of ATD therapy especially early in treatment
If total T3 & free T4 normailze can move to definitive therapy
Levothyroxine rxn for differentiated epithelial( papillary & follicular) thyroid ca?
Small, low risk tumors: target tsh 0.1-0.5 for 6-12 months, then low normal range Intermediate risk tumors: target tsh 0.1-0.5 Large, aggressive tumors: target tsh<0.1; continue for several years # suppresive doses of levo a/w inc risk of bone loss & AF so degree of tsh suppression depends on initial tumor stage & risk of recurrence